Mini review: hookworm-related cutaneous larva migrans

Review

Abstract

Hookworm-related cutaneous larva migrans (HrCLM) is a parasitic skin disease caused by the migration of animal hookworm larvae in the epidermis. Since these larvae cannot penetrate the basal membrane of human skin, they remain confined to the epidermis and are unable to develop and complete their lifecycle. By consequence, HrCLM is a self-limiting disease. However, if not treated promptly, the skin pathology may persist for months. HrCLM is endemic in many resource-poor communities in the developing world. In high-income countries, HrCLM occurs sporadically or in the form of small epidemics. Travelers account for the great majority of cases seen by health-care professionals in high-income countries. Transmission occurs when naked skin comes into contact with contaminated soil. Exposure may also occur indoors. Exceptionally, larvae may be transmitted through fomites. The first clinical sign is a small reddish papule. Thereafter, the characteristic serpiginous, slightly elevated, erythematous track becomes visible. Itching becomes more and more intense. Excoriations induced by scratching facilitate bacterial superinfection of the lesion. The diagnosis is essentially clinical. It is supported by a recent travel history and the possibility of exposure. The drug of choice is ivermectin in a single dose (200 μg per kg bodyweight). Repeated treatments with albendazole (400 mg daily) are a good alternative in countries where ivermectin is not available.

References

  1. 1.
    Caumes E, Danis M (2004) From creeping eruption to hookworm-related cutaneous larva migrans. Lancet Infect Dis 4:659–660PubMedCrossRefGoogle Scholar
  2. 2.
    Beaver PC (1956) Larva migrans. Exp Parasitol 5:587–621PubMedCrossRefGoogle Scholar
  3. 3.
    Haas W, Haberl B, Syafruddin, Idris I, Kallert D, Kersten S, Stiegeler P; Syafruddin (2005) Behavioural strategies used by the hookworms Necator americanus and Ancylostoma duodenale to find, recognize and invade the human host. Parasitol Res 95:30–39PubMedCrossRefGoogle Scholar
  4. 4.
    Blackwell V, Vega-Lopez F (2001) Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. Br J Dermatol 145:434–437PubMedCrossRefGoogle Scholar
  5. 5.
    Caumes E, Carrière J, Guermonprez G, Bricaire F, Danis M, Gentilini M (1995) Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 20:542–548PubMedCrossRefGoogle Scholar
  6. 6.
    Hochedez P, Caumes E (2007) Hookworm-related cutaneous larva migrans. J Travel Med 14:326–333PubMedCrossRefGoogle Scholar
  7. 7.
    Jelinek T, Maiwald H, Nothdurft HD, Löscher T (1994) Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis 19:1062–1066PubMedCrossRefGoogle Scholar
  8. 8.
    Richey TK, Gentry RH, Fitzpatrick JE, Morgan AM (1996) Persistent cutaneous larva migrans due to Ancylostoma species. South Med J 89:609–611PubMedCrossRefGoogle Scholar
  9. 9.
    Gutiérrez de la Solana Dumas J, Alvarez Mesa M, Manzur Katrib J (1983) An outbreak of cutaneous larva migrans. Rev Cubana Med Trop 35:303–316PubMedGoogle Scholar
  10. 10.
    Heukelbach J, Wilcke T, Meier A, Sabóia Moura RC, Feldmeier H (2003) A longitudinal study on cutaneous larva migrans in an impoverished Brazilian township. Travel Med Infect Dis 1:213–218PubMedCrossRefGoogle Scholar
  11. 11.
    Heukelbach J, Wilcke T, Feldmeier H (2004) Cutaneous larva migrans (creeping eruption) in an urban slum in Brazil. Int J Dermatol 43:511–515PubMedCrossRefGoogle Scholar
  12. 12.
    Heukelbach J, Jackson A, Ariza L, Feldmeier H (2008) Prevalence and risk factors of hookworm-related cutaneous larva migrans in a rural community in Brazil. Ann Trop Med Parasitol 102:53–61PubMedCrossRefGoogle Scholar
  13. 13.
    Jackson A, Heukelbach J, Calheiros CML, de Lima Soares V, Harms G, Feldmeier H (2006) A study in a community in Brazil in which cutaneous larva migrans is endemic. Clin Infect Dis 43:e13–e18PubMedCrossRefGoogle Scholar
  14. 14.
    Lee CP, Bishop LJ (1988) The incidence of cutaneous larva migrans in Montserrat, Leeward Islands, West Indies. West Indian Med J 37:22–24PubMedGoogle Scholar
  15. 15.
    Sandground JH (1939) Creeping eruptions in the Netherland East Indies caused by the invasion of the larva of Ancylostoma braziliense. Geneesk Tijdschr Ned Indië 13:805–810Google Scholar
  16. 16.
    Santarém VA, Giuffrida R, Zanin GA (2004) Cutaneous larva migrans: reports of pediatric cases and contamination by Ancylostoma spp larvae in public parks in Taciba, São Paulo State. Rev Soc Bras Med Trop 37:179–181PubMedCrossRefGoogle Scholar
  17. 17.
    Guimarães AM, Alves EG, de Rezende GF, Rodrigues MC (2005) Toxocara sp. eggs and Ancylostoma sp. larva in public parks, Brazil. Rev Saude Publica 39:293–295PubMedCrossRefGoogle Scholar
  18. 18.
    Beattie PE, Fleming CJ (2002) Cutaneous larva migrans in the west coast of Scotland. Clin Exp Dermatol 27:248–249PubMedCrossRefGoogle Scholar
  19. 19.
    Bradley J (1999) Home-grown cutaneous larva migrans. N Z Med J 112:241–242PubMedGoogle Scholar
  20. 20.
    Diba VC, Whitty CJ, Green T (2004) Cutaneous larva migrans acquired in Britain. Clin Exp Dermatol 29:555–556PubMedCrossRefGoogle Scholar
  21. 21.
    Herrmann A, Christoph T, Sebastian G (2004) Larva migrans “saxoniae”: larva migrans infection in Saxony. J Dtsch Dermatol Ges 2:46–48PubMedCrossRefGoogle Scholar
  22. 22.
    Klose C, Mravak S, Geb M, Bienzle U, Meyer CG (1996) Autochthonous cutaneous larva migrans in Germany. Trop Med Int Health 1:503–504PubMedCrossRefGoogle Scholar
  23. 23.
    Zimmermann R, Combemale P, Piens MA, Dupin M, Le Coz C (1995) Cutaneous larva migrans, autochthonous in France. Apropos of a case. Ann Dermatol Venereol 122:711–714PubMedGoogle Scholar
  24. 24.
    Conde JF, Feldman SR, Vallejos QM, Quandt SA, Whalley LE, Brooks T, Cabral G, Fleischer AB Jr, Arcury TA (2007) Cutaneous larva migrans in a migrant latino farmworker. J Agromedicine 12:45–48PubMedCrossRefGoogle Scholar
  25. 25.
    Bouchaud O, Houzé S, Schiemann R, Durand R, Ralaimazava P, Ruggeri C, Coulaud JP (2000) Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis 31:493–498PubMedCrossRefGoogle Scholar
  26. 26.
    Davies HD, Sakuls P, Keystone JS (1993) Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol 129:588–591PubMedCrossRefGoogle Scholar
  27. 27.
    Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, Von Sonnenburg F, Keystone JS, Pandey P, Cetron MS; GeoSentinel Surveillance Network (2006) Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354:119–130PubMedCrossRefGoogle Scholar
  28. 28.
    Heukelbach J, Gomide M, Araújo F Jr, Pinto NSR, Santana RD, Brito JRM, Feldmeier H (2007) Cutaneous larva migrans and tungiasis in international travelers exiting Brazil: an airport survey. J Travel Med 14:374–380PubMedCrossRefGoogle Scholar
  29. 29.
    Robson NZ, Othman S (2008) A case of cutaneous larva migrans acquired from soiled toilet floors in urban Kuala Lumpur. Med J Malaysia 63:331–332PubMedGoogle Scholar
  30. 30.
    Tomović M, Skiljević D, Zivanović D, Tanasilović S, Vesić S, Daković Z, Vukićević J, Pavlović MD, Medenica L (2008) Two cases of probable endogenous extensive cutaneous larva migrans in Serbia. Acta Dermatovenerol Alp Panonica Adriat 17:37–40PubMedGoogle Scholar
  31. 31.
    Galanti B, Fusco FM, Nardiello S (2002) Outbreak of cutaneous larva migrans in Naples, southern Italy. Trans R Soc Trop Med Hyg 96:491–492PubMedCrossRefGoogle Scholar
  32. 32.
    Tremblay A, MacLean JD, Gyorkos T, Macpherson DW (2000) Outbreak of cutaneous larva migrans in a group of travellers. Trop Med Int Health 5:330–334PubMedCrossRefGoogle Scholar
  33. 33.
    Fülleborn F (1926) Experimentally generated “creeping eruption”. Dermatol Wochenschr 83:1474–1475Google Scholar
  34. 34.
    Siriez JY, Angoulvant F, Buffet P, Cleophax C, Bourrat E (2010) Individual variability of the cutaneous larva migrans (CLM) incubation period. Pediatr Dermatol 27:211–212PubMedCrossRefGoogle Scholar
  35. 35.
    Veraldi S, Arancio L (2006) Giant bullous cutaneous larva migrans. Clin Exp Dermatol 31:613–614PubMedCrossRefGoogle Scholar
  36. 36.
    Caumes E, Ly F, Bricaire F (2002) Cutaneous larva migrans with folliculitis: report of seven cases and review of the literature. Br J Dermatol 146:314–316PubMedCrossRefGoogle Scholar
  37. 37.
    Veraldi S, Bottini S, Carrera C, Gianotti R (2005) Cutaneous larva migrans with folliculitis: a new clinical presentation of this infestation. J Eur Acad Dermatol Venereol 19:628–630PubMedCrossRefGoogle Scholar
  38. 38.
    van Nispen tot Pannerden C, van Gompel F, Rijnders BJ, Caumes E, den Hollander JG (2007) An itchy holiday. Neth J Med 65:188–190PubMedGoogle Scholar
  39. 39.
    Veraldi S, Persico MC (2007) HIV, cutaneous larva migrans and fever. Int J STD AIDS 18:433–434PubMedCrossRefGoogle Scholar
  40. 40.
    Schuster A, Lesshaft H, Reichert F, Ignatius H, Feldmeier H (2011) Life quality impairment caused by hookworm-related cutaneous larva migrans (CLM) in resource-poor communities in Manaus, Brazil. PLoS Negl Trop Dis (in press)Google Scholar
  41. 41.
    Veraldi S, Schianchi R, Carrera C (2000) Epiluminescence microscopy in cutaneous larva migrans. Acta Derm Venereol 80:233PubMedGoogle Scholar
  42. 42.
    Malvy D, Ezzedine K, Pistone T, Receveur MC, Longy-Boursier M (2006) Extensive cutaneous larva migrans with folliculitis mimicking multimetameric herpes zoster presentation in an adult traveler returning from Thailand. J Travel Med 13:244–247PubMedCrossRefGoogle Scholar
  43. 43.
    Sakai H, Otsubo S, Nakao M, Yamasaki H, Kagei N, Iizuka H (2008) Multiple papules and nodules on the face and neck caused by the larvae of an unknown nematode: a noncreeping type eruption. J Am Acad Dermatol 58:668–670PubMedCrossRefGoogle Scholar
  44. 44.
    Yap FB-B (2011) Cutaneous larva migrans in Hospital Kuala Lumpur, Malaysia: rate of correct diagnosis made by the referring primary care doctors. Trans R Soc Trop Med Hyg 105:405–408PubMedCrossRefGoogle Scholar
  45. 45.
    Caumes E, Carrière J, Datry A, Gaxotte P, Danis M, Gentilini M (1993) A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 49:641–644PubMedGoogle Scholar
  46. 46.
    Caumes E, Datry A, Paris L, Danis M, Gentilini M, Gaxotte P (1992) Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol 128:994–995PubMedCrossRefGoogle Scholar
  47. 47.
    Caumes E (2003) Treatment of cutaneous larva migrans and Toxocara infection. Fundam Clin Pharmacol 17:213–216PubMedCrossRefGoogle Scholar
  48. 48.
    Van den Enden E, Stevens A, Van Gompel A (1998) Treatment of cutaneous larva migrans. N Engl J Med 339:1246–1247PubMedCrossRefGoogle Scholar
  49. 49.
    Sanguigni S, Marangi M, Teggi A, De Rosa F (1990) Albendazole in the therapy of cutaneous larva migrans. Trans R Soc Trop Med Hyg 84:831PubMedCrossRefGoogle Scholar
  50. 50.
    Veraldi S, Rizzitelli G (1999) Effectiveness of a new therapeutic regimen with albendazole in cutaneous larva migrans. Eur J Dermatol 9:352–353PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Institute of Microbiology and HygieneCharité University MedicineBerlinGermany

Personalised recommendations